Research programme: small molecule therapeutics - University of Texas M. D. Anderson Cancer Center/X-Chem

Drug Profile

Research programme: small molecule therapeutics - University of Texas M. D. Anderson Cancer Center/X-Chem

Latest Information Update: 08 Jan 2016

Price : $50

At a glance

  • Originator University of Texas M. D. Anderson Cancer Center; X-Chem
  • Class Antineoplastics; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Cancer

Most Recent Events

  • 06 Jan 2016 Early research in Cancer in USA (unspecified route)
  • 06 Jan 2016 X-Chem and MD Anderson Cancer Center agree to co- co-develop Small molecule therapeutics for cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top